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Abstract Human islet amyloid polypeptide (hIAPP)
forms amyloid ﬁbrils in pancreatic islets of patients with
type 2 diabetes mellitus. It has been suggested that the
N-terminal part, which contains a conserved intramolecular
disulﬁde bond between residues 2 and 7, interacts with
membranes, ultimately leading to membrane damage and
b-cell death. Here, we used variants of the hIAPP1–19
fragment and model membranes of phosphatidylcholine
and phosphatidylserine (7:3, molar ratio) to examine the
role of this disulﬁde in membrane interactions. We found
that the disulﬁde bond has a minor effect on membrane
insertion properties and peptide conformational behavior,
as studied by monolayer techniques,
2H NMR, ThT-ﬂuo-
rescence, membrane leakage, and CD spectroscopy. The
results suggest that the disulﬁde bond does not play a
signiﬁcant role in hIAPP–membrane interactions. Hence,
the fact that this bond is conserved is most likely related
exclusively to the biological activity of IAPP as a hormone.
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Introduction
Type 2 diabetes mellitus (DM2) is characterized histopa-
thologically by the presence of ﬁbrillar amyloid deposits in
the pancreatic islets of Langerhans (islet amyloid). The
main component of these amyloid ﬁbrils is the 37-amino-
acid residue human islet amyloid polypeptide (hIAPP), a
hormone that is normally co-secreted with insulin by the
b-cells of the pancreas (Westermark et al. 1987). Although
the normal physiological role of hIAPP is not entirely
clear, it has been shown that the peptide plays a role as a
hormone in suppression of gastric emptying, food intake,
and glucose homeostasis (Akesson et al. 2003; Reda et al.
2002; Rushing et al. 2001).
It is thought that hIAPP amyloid formation is cytotoxic
to the islet b-cells (Ho ¨ppener et al. 2000; Khemte ´mourian
et al. 2008), and that this cytotoxicity involves membrane
disruption by growing IAPP ﬁbrils (Engel et al. 2008)o rb y
toxic hIAPP oligomers (Demuro et al. 2005; Engel 2009;
Jayasinghe and Langen 2007; Kayed et al. 2003). It is well
established that hIAPP is able to interact with membranes
and that membranes can promote the aggregation of hIAPP
(Knight and Miranker 2004; Janson et al. 1999; Sparr et al.
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hIAPP is insertion of its N-terminus, most likely as the
monomer (Engel et al. 2006). This N-terminus contains an
evolutionary conserved disulﬁde bond between Cys2 and
Cys7, presumably formed in the oxidizing environment of
the endoplasmic reticulum. This disulﬁde bond has been
shown to be essential for biological activity of hIAPP, i.e.
its effect on insulin-stimulated glycogen synthesis (Roberts
et al. 1989). Possibly related to this, an important role for
the disulﬁde bridge was demonstrated in heparin binding
(Abedini et al. 2006). With regard to its role in amyloid
formation, it has been shown that the disulﬁde prohibits the
N-terminal region of hIAPP from adopting a b-sheet-rich
structure (characteristic of amyloid ﬁbrils) and that it is
involved in amyloid formation in solution, albeit not as part
of the core (Koo and Miranker 2005). However, to our
knowledge no reports have yet been published on the
possible role of the disulﬁde bond of hIAPP in membrane-
interaction.
Because the disulﬁde bond is located in the N-terminal
part of the peptide, and because the N-terminal part is
primarily responsible for the interaction of hIAPP with
membranes, we examined the effect of this disulﬁde on
insertion of the peptide hIAPP1–19 into membranes. In
particular, we have examined the aggregational behavior,
the membrane insertion, the secondary structure and the
effect on lipid acyl chain order and on membrane leakage.
For this purpose, we generated two hIAPP1–19 peptides
(oxidized and protected hIAPP1–19, Fig. 1) and we inves-
tigated their interaction with model membranes composed
of a mixture of the zwitterionic lipid phosphatidylcholine
(POPC) and the anionic lipid phosphatidylserine (POPS) in
a 7:3 ratio to mimic the membranes of pancreatic islet cells
(Rustenbeck et al. 1994).
Materials and methods
Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS),
and chain perdeuterated POPC and POPS (POPC-
2H31 and
POPS-
2H31) were purchased from Avanti Polar Lipids
(Alabaster, AL, USA).
Peptide synthesis and puriﬁcation
The peptides (see Fig. 1 for the amino acid sequence) were
synthesized using Fmoc chemistry on a Tentagel S RAM
resin to provide an amidated C-terminus. Fmoc–Cys(Me)–
OH was used for the synthesis of the protected peptide;
Fmoc–Cys(Trt)–OH was used for the synthesis of the linear
peptide. Linear hIAPP1–19 was dissolved in aqueous
DMSO and oxidized with air to the corresponding disulﬁde
bond. All peptides were puriﬁed by HPLC using an Alltima
C8 column (100 A ˚ pore size, 10 lm particle size,
25 9 2.2 cm). The peptides were eluted with a ﬂow rate of
12.5 ml/min. using a linear gradient of buffer B (100% in
100 min) from 100% buffer A (0.1% TFA in CH3CN–H2O
5:95 v/v), buffer B (0.1% TFA in CH3CN–H2O9 5 : 5v/v).
Purity of the peptides was higher than 95% as determined
by analytical HPLC, and the masses of the peptides were
conﬁrmed with MALDI-TOF mass spectrometry.
Preparation of peptide samples
Peptide stock solutions were prepared by dissolving the
peptide at a concentration of 1 mM in hexaﬂuoroisopro-
panol (HFIP) and incubating for at least 1 h. Next, HFIP
was evaporated, followed by vacuum desiccation for
20 min. The resulting peptide ﬁlm was then dissolved to a
ﬁnal peptide concentration of 1 mM in either DMSO for
the monolayer or in an appropriate buffer containing the
vesicles for the CD and the NMR experiments.
Monolayer experiments
Peptide-induced changes in the surface pressure of a
monomolecular layer of phospholipids at constant surface
area were measured with the Wilhelmy plate method, as
reported previously (Engel et al. 2006). Surface pressures
were measured at 22(±2)C. Brieﬂy, a Teﬂon trough was
ﬁlled with 6.0 ml 10 mM Tris–HCl, 100 mM NaCl buffer
(pH 7.4). Lipid monolayers were spread from a 1 mM
stock solution in chloroform, after which 10 llo fa
600 lM freshly prepared stock solution of the peptide was
injected into the sub-phase. The ﬁnal peptide concentration
was 1 lM.
Preparation of LUVs (large unilamellar vesicles)
LUVs were prepared from POPC/POPS in a 7:3 molar
ratio. Stock solutions of POPC and POPS in chloroform at
concentrations of 20–30 mM were mixed in a 7:3 molar
ratio in a glass tube. The solvent was evaporated with dry
nitrogen gas yielding a lipid ﬁlm that was subsequently
kept in a vacuum desiccator for 20 min. Lipid ﬁlms were
hydrated in 10 mM phosphate buffer (pH 7.4) for at least
Fig. 1 Amino acid sequences of oxidized and protected hIAPP1–19.
Both peptides have an amidated C-terminus
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suspensions were subjected to ten freeze–thaw cycles, at
temperatures of approximately -80 and 40C, and subse-
quently extruded ten times through 0.2 lm pore-size ﬁlters
(Anotop 10; Whatman, Maidstone, UK).
CD spectroscopy
CD spectra were acquired on a Jasco 810 spectropolar-
imeter (Jasco, Easton, MD, USA) over the wavelength
range 190–270 nm at room temperature. Measurements
were carried out in cells of 0.1 mm path length at room
temperature in POPC/POPS (7:3) LUVs. Measurements
were taken every 0.2 nm at a scan rate of 20 nm/min.
Each spectrum reported is the average of ﬁve scans after
subtraction of the baseline spectrum of the vesicles
without peptide. Peptide concentrations were 50 lMi n
the presence of lipids (peptide-to-lipid ratio 1:20). In
order to estimate the peptide secondary structure content,
analysis of relevant CD spectra was carried out using
CDPro2 software (Sreerama and Woody 2000). The
analysis was performed using the self-consistent method
Contin-LL and the basis 10 that contains 56 reference
proteins.
Sample preparation for NMR experiments
Mixtures of POPC and POPS (ratio 7:3) were co-dissolved
in chloroform and evaporated under vacuum. The residual
lipid ﬁlm was hydrated in Tris–HCl, 100 mM NaCl buffer
(pH 7.4). The solution was subjected to ten freeze–thaw
cycles, at temperatures of approximately -80 and 40C, to
homogenize the size of the MLV. For the samples con-
taining the peptide, the lipid solution was added to the ﬁlm
of peptide at the beginning of the MLV preparation. A total
lipid-to-peptide ratio of 20:1 was used.
NMR experiments
NMR experiments were carried out on a Bruker Advance
500 MHz NMR spectrometer.
2H NMR experiments on
deuterated lipids were performed at 76.78 MHz using a
quadrupolar echo sequence. Typical acquisition conditions
were: 2.5 ls9 0  pulse, an echo delay of 50 ls, a recycling
delay of 1.5 s, 500 kHz spectral width, 4096 data points,
36000 scans. A line broadening of 100–200 Hz was
applied prior to Fourier transformation. The temperature
was regulated at 25 ± 1C. To gather information about
effects of the peptides on local chain order, powder spectra
were processed using the ‘‘de-Pake-ing’’ procedure,
implemented by Bloom et al. (1981). The order parameters,
SCD, were calculated by use of NMRFriend software
(Buchoux et al. 2008).
Results and discussion
To evaluate the role of the disulﬁde bond in hIAPP1–19 on
its membrane interactions, we synthesized two hIAPP1–19
peptides: an oxidized form and a protected form with a
methyl group on each cysteine residue to avoid the for-
mation of the disulﬁde bond during the experiments. The
amino acid sequences of the peptides are shown in Fig. 1.
The oxidized peptide has a slightly higher tendency
to insert than the protected peptide
Tostudytheinsertionofthepeptidesinlipidmembranes,we
performedmonolayerexperiments.Injectionofasolutionof
either oxidizedor protected hIAPP1–19 intothe aqueoussub-
phase below a POPC/POPS (7:3) monolayer resulted in a
fast increase in the surface pressure after addition of each
peptide. After 20 min, at an initial surface pressure of
24 mN/m, the increase in surface pressure induced by
insertion of the oxidized hIAPP1–19 was 9.0 ± 0.5 mN/m,
compared with an increase of 7.5 ± 0.5 mN/m for the
protected hIAPP1–19 (Fig. 2a), indicating efﬁcient insertion
for both peptides.
Next, we determined the maximal initial surface pres-
sure at which the peptides were still able to insert, i.e. cause
a further increase in surface pressure, by analysing the
surface pressure increase as a function of initial surface
pressure. The data from Fig. 2b indicate that the extrapo-
lated ‘‘limiting surface pressure’’ is high for all peptides
and it seems to be slightly higher for the oxidized peptide
(47.2 ± 0.7 mN/m) than for the protected peptide
(44.7 ± 0.8 mN/m). In both cases, the limiting surface
pressure is signiﬁcantly higher than the surface pressures
that correspond to the packing density in lipids in biolog-
ical membranes, between 31 and 35 mN/m (Demel et al.
1975), indicating that in vivo also hIAPP1–19 can insert
efﬁciently into membranes. The limiting surface pressure
of hIAPP is of the same order, or even higher, than that of
peptides with a known membrane activity, for example
neuropeptides and antimicrobial peptides (Calvez et al.
2009). Thus, our results suggest that both peptides insert
very efﬁciently into membranes, but that the oxidized
peptide has a slightly higher capacity to insert than the
protected peptide.
The oxidized peptide induces slightly more acyl chain
disorder than the protected peptide
Next we investigated the effect of membrane insertion of
these peptides on lipid chain order by
2H NMR. The pep-
tides were incorporated into bilayers of perdeuterated
POPC/POPS at a 1:20 peptide-to-lipid molar ratio.
31P
NMR measurements conﬁrmed that the lipids in these
Eur Biophys J (2010) 39:1359–1364 1361
123systems are in a bilayer organization (data not shown).
Figure 3a presents the
2H NMR spectra of POPC-
2H31/
POPS bilayer dispersions, with and without the peptides at
25C. In the case of POPC-
2H31/POPS, we observe the
typical behavior of this system, characteristic of a lamellar
ﬂuid phase (Salnikov et al. 2009). The spectra exhibit many
resolved splittings. The smallest splitting, corresponding to
the methyl groups at the end of the acyl chains, is about
5.0 kHz and the largest, corresponding to the CD2 groups
closest to the glycerol backbone, is approximately
25.9 kHz. In the presence of the peptides, no characteristic
changes in spectrum shape occur. Thus, addition of the
oxidized peptide or the protected peptide does not induce a
global perturbation of the dynamics of the membrane
matrix. However, the width of the spectra seems slightly
reduced, with the largest splitting now being 24.9 kHz for
the protected peptide and 24.1 kHz for the oxidized pep-
tide. Figure 3b shows the proﬁle of the order parameter
(SCD) for each carbon position in the lipid chain in the
presence and in the absence of peptide. The POPC-
2H31
chain order is lower when either peptide is present in the
system. This is particularly true for the ‘‘plateau’’ positions
(carbons 2 to 6). Toward the chain end (positions 15 and
16) the effect is less marked or absent. In addition, our
results show that the POPC-
2H31 chain order is lower with
the oxidized peptide than with the protected one. The
2H
NMR spectra of POPC/POPS-
2H31 bilayer dispersions
were also recorded. The same effect as for the POPC-
2H31/
Fig. 2 a Surface pressure proﬁle after injecting a sample of
hIAPP1–19 oxidized (solid line) and protected (dashed line) into a
monolayer of POPC/POPS (7:3). The peptides were injected into the
stirred sub-phase at t = 0 min. The ﬁnal peptide concentration was
1 lM. b Surface pressure increase induced by the interaction of
freshly dissolved hIAPP1–19 oxidized (diamonds, solid line) and
protected (triangles, dashed line) with POPC/POPS (7:3) monolayers
as a function of the initial surface pressure. The ﬁnal peptide
concentration was 1 lM. The straight lines were obtained by linear
regression. Experimental error is estimated at ±0.5 mN/m
Fig. 3 a
2H NMR spectra for peptides/POPC-d31/POPS dispersions
at a 1:20 molar ratio and at 25C. Spectra are shown without peptide
and for samples containing the peptides indicated. b SCD proﬁle
without peptide (squares), with hIAPP1–19 oxidized (diamonds) and
protected (triangles) calculated for de-Paked spectra at 25C. Carbon
position 16 represents the end of the chain. Experimental error is in
symbol size
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123POPS bilayer was observed. The membrane-disorder
induced by hIAPP is of the same order as that of peptides
with a known membrane activity, for example antimicro-
bial peptides (Salnikov et al. 2009; Balla et al. 2004). In
addition, it was recently shown that Ab42, the peptide that
forms amyloid ﬁbrils in Alzheimer’s disease, also induced
membrane disorder in POPC/POPS bilayers (Gehman et al.
2008; Lau et al. 2006). This result can be correlated with
that of the monolayer study: the oxidized peptide inserts
better and induces more disorder into the membrane than
the protected peptide, suggesting that the disulﬁde bond
somewhat affects the mode of membrane insertion of
hIAPP1–19.
The oxidized peptide has slightly less a-helical
structure than the protected peptide in the presence
of membranes
The small differences in mode of insertion of the oxidized
and protected peptide may be because of differences in
conformation. We therefore used CD spectroscopy to
determine whether the disulﬁde bridge affects the mem-
brane-bound secondary structure of the peptide in the
presence of POPC/POPS membranes. A previous study
showed that oxidized hIAPP1–19 adopts a-helical structure
upon addition of POPG liposomes (Brender et al. 2008).
Consistent with this, our CD spectra in POPC/POPS (7:3)
of the oxidized peptide display negative ellipticity at 208
and 222 nm, characteristic of a-helical backbone structure
(Fig. 4). A similar spectrum is observed for the protected
peptide. However, the minimum of the protected peptide is
slightly more intense than the minimum of the oxidized
peptide. This suggests that the protected peptide has a
slightly larger a-helical content than the oxidized peptide.
This is supported by deconvolution of CD traces, where
62% a-helical contribution is obtained for the protected
peptide and 58% a-helical for the oxidized peptide (inset of
Fig. 4). This result suggests that in the presence of mem-
branes the disulﬁde bond only slightly affects the second-
ary structure of hIAPP1–19.
The disulﬁde bond does not inﬂuence the effect of
hIAPP1–19 on membrane barrier properties or its
inability to form amyloid ﬁbers
We wanted to know if the disulﬁde has an effect on mem-
brane damage and ﬁbril formation. Membrane damage was
assayed quantitatively by analyzing the extent of leakage of
a ﬂuorescent dye (calcein) from LUVs. The results demon-
strate that neither peptide is able to induce signiﬁcant
membrane damage (leakage\5%, data not shown), despite
their abilityto efﬁcientlyinsert into a lipidmonolayer andto
induce slight bilayer disorder. Also, under these conditions,
i.e. in the presence of POPC/POPS LUVs, neither peptide
forms ﬁbrils as determined by transmission electron
microscopy and thioﬂavin T ﬂuorescence, even after
15 days of incubation (data not shown). These ﬁndings are
in agreement with our previous work, which indicated that
ﬁbril growth is a requirement for amyloid-induced mem-
brane damage (Engel et al. 2008).
Conclusion
Our results suggest that the presence of the disulﬁde bond
has only small effects on membrane interaction of hIAPP.
Its removal in hIAPP1–19 results in a slight decrease in
membrane insertion, a decrease in the effect of the peptide
on membrane disorder, and a small increase in a-helical
structure. The inability of hIAPP1–19 to induce membrane
damage and to form ﬁbrils in the presence of membranes is
not changed upon removing the disulﬁde bond.
Based on the results presented here, and on our previous
results (Engel et al. 2006), we conclude that the N-terminal
residues of IAPP are important for membrane insertion, but
that the disulﬁde linked residues 2–7 seem much less
responsible than the other residues (8–19) for this inter-
action. This notion is in agreement with two recent studies,
which indicate that residues 9 to 22 of hIAPP form a helix
that binds to phospholipid bilayers (Apostolidou et al.
2008; Nanga et al. 2009) whereas residues 1 to 8, con-
taining the disulﬁde, do not interact directly with the
membrane. Thus, the fact that the cysteines are evolu-
tionarily conserved is most likely related exclusively to the
biological activity of IAPP as a hormone, where these
cysteines may be involved in interactions with other cel-
lular components than lipids, e.g. with an IAPP receptor.
Fig. 4 CD spectra of 50 lM hIAPP1–19 oxidized (bold line) and
protected (thin line) in the presence of POPC/POPS 7:3 LUVs
(peptide-to-lipid ratio 1:20). The inset shows the deconvolution of CD
spectra of the peptides
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